The effect of renal impairment and haemodialysis on single dose pharmacokinetics of oral enoxacin

David E. Nix, R. W. Schultz, R. W. Frost, A. J. Sedman, D. J. Thomas, A. W. Kinkel, J. J. Schentag

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

The effect of renal impairment on the single dose pharmacokinetics of oral enoxacin was studied in 28 volunteers with creatinine clearances ranging from less than 15 to 120 ml/min, including patients undergoing chronic haemodialysis. Following an overnight fast, 400 mg of enoxacin was administered orally to each subject. Blood and urine samples were collected at predetermined times for 48 and 72 h, respectively. Plasma and urine samples were assayed for enoxacin and for oxo metabolite concentrations by a specific high performance liquid chromatographic method. Area under the concentration-time curve from time 0 to infinity (AUC(0-∞)) was increased in subjects with renal impairment. Plasma half-life (10.6-11.6 h) in volunteers with severe renal impairment was approximately double the 5.2 h half-life found in subjects with normal renal function, and this should result in steady-state enoxacin concentrations approximately double those measured in normal subjects given equivalent doses. Haemodialysis did not remove significant amounts of enoxacin. A significant correlation between creatinine clearance and enoxacin renal clearance was observed (r = 0.97).

Original languageEnglish (US)
Pages (from-to)87-95
Number of pages9
JournalJournal of Antimicrobial Chemotherapy
Volume21
Issue numberSUPPL. B
StatePublished - 1988
Externally publishedYes

Fingerprint

Enoxacin
Renal Dialysis
Pharmacokinetics
Kidney
Half-Life
Volunteers
Creatinine
Urine
Area Under Curve

ASJC Scopus subject areas

  • Microbiology
  • Pharmacology

Cite this

Nix, D. E., Schultz, R. W., Frost, R. W., Sedman, A. J., Thomas, D. J., Kinkel, A. W., & Schentag, J. J. (1988). The effect of renal impairment and haemodialysis on single dose pharmacokinetics of oral enoxacin. Journal of Antimicrobial Chemotherapy, 21(SUPPL. B), 87-95.

The effect of renal impairment and haemodialysis on single dose pharmacokinetics of oral enoxacin. / Nix, David E.; Schultz, R. W.; Frost, R. W.; Sedman, A. J.; Thomas, D. J.; Kinkel, A. W.; Schentag, J. J.

In: Journal of Antimicrobial Chemotherapy, Vol. 21, No. SUPPL. B, 1988, p. 87-95.

Research output: Contribution to journalArticle

Nix, DE, Schultz, RW, Frost, RW, Sedman, AJ, Thomas, DJ, Kinkel, AW & Schentag, JJ 1988, 'The effect of renal impairment and haemodialysis on single dose pharmacokinetics of oral enoxacin', Journal of Antimicrobial Chemotherapy, vol. 21, no. SUPPL. B, pp. 87-95.
Nix, David E. ; Schultz, R. W. ; Frost, R. W. ; Sedman, A. J. ; Thomas, D. J. ; Kinkel, A. W. ; Schentag, J. J. / The effect of renal impairment and haemodialysis on single dose pharmacokinetics of oral enoxacin. In: Journal of Antimicrobial Chemotherapy. 1988 ; Vol. 21, No. SUPPL. B. pp. 87-95.
@article{8dd27b386bed4b4a98cf56cbeb31699e,
title = "The effect of renal impairment and haemodialysis on single dose pharmacokinetics of oral enoxacin",
abstract = "The effect of renal impairment on the single dose pharmacokinetics of oral enoxacin was studied in 28 volunteers with creatinine clearances ranging from less than 15 to 120 ml/min, including patients undergoing chronic haemodialysis. Following an overnight fast, 400 mg of enoxacin was administered orally to each subject. Blood and urine samples were collected at predetermined times for 48 and 72 h, respectively. Plasma and urine samples were assayed for enoxacin and for oxo metabolite concentrations by a specific high performance liquid chromatographic method. Area under the concentration-time curve from time 0 to infinity (AUC(0-∞)) was increased in subjects with renal impairment. Plasma half-life (10.6-11.6 h) in volunteers with severe renal impairment was approximately double the 5.2 h half-life found in subjects with normal renal function, and this should result in steady-state enoxacin concentrations approximately double those measured in normal subjects given equivalent doses. Haemodialysis did not remove significant amounts of enoxacin. A significant correlation between creatinine clearance and enoxacin renal clearance was observed (r = 0.97).",
author = "Nix, {David E.} and Schultz, {R. W.} and Frost, {R. W.} and Sedman, {A. J.} and Thomas, {D. J.} and Kinkel, {A. W.} and Schentag, {J. J.}",
year = "1988",
language = "English (US)",
volume = "21",
pages = "87--95",
journal = "Journal of Antimicrobial Chemotherapy",
issn = "0305-7453",
publisher = "Oxford University Press",
number = "SUPPL. B",

}

TY - JOUR

T1 - The effect of renal impairment and haemodialysis on single dose pharmacokinetics of oral enoxacin

AU - Nix, David E.

AU - Schultz, R. W.

AU - Frost, R. W.

AU - Sedman, A. J.

AU - Thomas, D. J.

AU - Kinkel, A. W.

AU - Schentag, J. J.

PY - 1988

Y1 - 1988

N2 - The effect of renal impairment on the single dose pharmacokinetics of oral enoxacin was studied in 28 volunteers with creatinine clearances ranging from less than 15 to 120 ml/min, including patients undergoing chronic haemodialysis. Following an overnight fast, 400 mg of enoxacin was administered orally to each subject. Blood and urine samples were collected at predetermined times for 48 and 72 h, respectively. Plasma and urine samples were assayed for enoxacin and for oxo metabolite concentrations by a specific high performance liquid chromatographic method. Area under the concentration-time curve from time 0 to infinity (AUC(0-∞)) was increased in subjects with renal impairment. Plasma half-life (10.6-11.6 h) in volunteers with severe renal impairment was approximately double the 5.2 h half-life found in subjects with normal renal function, and this should result in steady-state enoxacin concentrations approximately double those measured in normal subjects given equivalent doses. Haemodialysis did not remove significant amounts of enoxacin. A significant correlation between creatinine clearance and enoxacin renal clearance was observed (r = 0.97).

AB - The effect of renal impairment on the single dose pharmacokinetics of oral enoxacin was studied in 28 volunteers with creatinine clearances ranging from less than 15 to 120 ml/min, including patients undergoing chronic haemodialysis. Following an overnight fast, 400 mg of enoxacin was administered orally to each subject. Blood and urine samples were collected at predetermined times for 48 and 72 h, respectively. Plasma and urine samples were assayed for enoxacin and for oxo metabolite concentrations by a specific high performance liquid chromatographic method. Area under the concentration-time curve from time 0 to infinity (AUC(0-∞)) was increased in subjects with renal impairment. Plasma half-life (10.6-11.6 h) in volunteers with severe renal impairment was approximately double the 5.2 h half-life found in subjects with normal renal function, and this should result in steady-state enoxacin concentrations approximately double those measured in normal subjects given equivalent doses. Haemodialysis did not remove significant amounts of enoxacin. A significant correlation between creatinine clearance and enoxacin renal clearance was observed (r = 0.97).

UR - http://www.scopus.com/inward/record.url?scp=0023926558&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023926558&partnerID=8YFLogxK

M3 - Article

VL - 21

SP - 87

EP - 95

JO - Journal of Antimicrobial Chemotherapy

JF - Journal of Antimicrobial Chemotherapy

SN - 0305-7453

IS - SUPPL. B

ER -